Showing results (21-30 of 67) with videos related to
Sort By:
Pageof 7
The Biochemical Journal|October 11, 2005
Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus bindingJoel R Livingston, Michael R Sutherland, Harvey M Friedman, et al.Journal of Virology|January 14, 2011
The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivoJohn M Lubinski, Helen M Lazear, Sita Awasthi, et al.AIDS (London, England)|September 10, 2002
Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapyRobert Gross, Warren B Bilker, Harvey M Friedman, et al.Virology|July 6, 2010
Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axonsFushan Wang, Elizabeth E Zumbrun, Jialing Huang, et al.Vaccine|June 7, 2005
Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domainsYueh J Chang, Ming Jiang, John M Lubinski, et al.Vaccine|February 5, 2008
An HSV-1 gD mutant virus as an entry-impaired live virus vaccineSita Awasthi, John M Lubinski, Roselyn J Eisenberg, et al.Journal of Virology|March 31, 2006
Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibodyLauren M Hook, John M Lubinski, Ming Jiang, et al.Vaccine|December 16, 2018
A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infectionLauren M Hook, Sita Awasthi, Jonathan Dubin, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|April 10, 2020
Vaccines to prevent genital herpesKevin Egan, Lauren M Hook, Philip LaTourette, et al.Journal of Virology|June 20, 2008
A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccineElizabeth E Brittle, Fushan Wang, John M Lubinski, et al.Pageof 7